Mirae Asset Global Investments
QNTM

Mirae Asset Global Investments’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Mirae Asset Global Investments’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,039
Closed -$1.01M – 1649
2021
Q4 		$1.01M Buy
+15,039
New +$1.31M ﹤0.01% 1289

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Mirae Asset Global Investments's QNTM Position: Q1 2022 in Review

Mirae Asset Global Investments sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2022, closing a stake of 15,039 shares — an estimated $1.01M sold.

Mirae Asset Global Investments first reported a position in QNTM in Q4 2021 and held it in 1 quarter. The position peaked at $1.01M in Q4 2021. 19 funds tracked by Wall St. Rank hold QNTM as of Q1 2022.

  • Mirae Asset Global Investments reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 15,039 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2022, an estimated $1.01M.
  • Mirae Asset Global Investments first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2021 and held it in 1 quarter.
  • Mirae Asset Global Investments's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $1.01M in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2022.

Based on Mirae Asset Global Investments's 13F filing for Q1 2022, filed 10 May 2022.